RTOG Address
Search  
HomeMember InfoProtocolsResearcherMeetingsVisitorsFAQSite Map




RTOG News

CONTACT:
Sharon Hartson Stine Office: 215.717.0834
shartson@acr-arrs.org Mobile: 609.458.5604
 


09/15/09 Walter Curran, MD, New Director of Emory Winship Cancer Institute
   
09/10/09 RTOG 0915 SBRT for Stage I NSCLC Opened for Accrual
   
08/14/09 RTOG 9003: LOX Predicts Survival, Metastases for H&N Cancer
   
07/29/09 RTOG Email Address Format Change
   
07/27/09 RTOG 9309 NSCLC Results Published in Lancet
   
07/16/09 James Dignam, PhD, New RTOG Group Statistician
   
05/27/09 RTOG Reports on HPV Status of Oropharyngeal Cancers at ASCO
   
05/27/09 PCI Decreases Brain Mets Report at ASCO
   
05/27/09 Short-Course RT for Vertebral Bone Metastases at ASCO
   
05/26/09 Q. Ed Zhang, PhD, New Senior Statistician
   
03/25/09 Long-Term ADT Improves Survival on RTOG 8531
   
03/17/09 RTOG Receives Six-Year Renewal
   
02/25/09 Elizabeth M. Gore, MD, Elected RTOG Full Member Principal Investigators Chair
   
02/24/09 RTOG Names New Director of Protocol Development and Regulatory Compliance
   
01/09/09 Anthony M. Magliocco, MD, Named New RTOG Pathology Committee Chair
   
11/20/08 RTOG Reports that Chemotherapy Added to Radiotherapy Improves Survival for Low Grade Glioma Patients
   
11/20/08 RTOG Reports that Activation of PI3K Pathway Signaling is Associated with Adverse Outcome in Brain Tumor Patients
   
11/11/08 RTOG Presents Top Scoring Abstract at Society for Neuro-Oncology Annual Meeting
   
11/11/08 Daniel L. Hunt, Jr., Ph.D., New RTOG Senior Statistician
   
10/15/08 RTOG and US Oncology Enter Collaboration to Increase Patient Accrual to Clinical Trials
   
09/24/08 RTOG Finds Less Salivary Glad Toxicity in Patients Treated with IMRT for Oropharyngeal Cancer
   
09/22/08 RTOG Shows Early Aggressive Treatment Increases Survival for Some Brain Tumor Patients
   
09/22/08 Changes in Gene Expression During Treatment Predict Future Response for Women on RTOG Cervical Cancer Study
   
09/22/08 RTOG Study Shows Shorter Radiotherapy Schedule with 3DCRT is Effective as a Breast Conserving Therapy
   
09/16/08 RTOG Reports Recent Cancer Trial Results in 22 Presentations at ASTRO
   
05/31/08 RTOG Study: Adding Cetuximab to Chemotherapy and Radiotherapy Leads to Improved Outcome for Lung Cancer Patients
   
05/22/08 RTOG Study Likely Treatment Option for Brain Tumor Patients like Sen. Kennedy
   
04/23/08 Cisplatin Prior to Chemoradiation is Less Effective than Standard Treatment for Anal Canal Cancer
   
03/04/08 Addition of Gemcitabine to Standard Therapy After Surgery Improves Survival for Pancreatic Cancer Patients
   





RTOG Meeting | January 20-23, 2005 Sheraton Wild Horse Pass Resort, Phoenix, Arizona